These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 20503268)

  • 1. Survivin and escaping in therapy-induced cellular senescence.
    Wang Q; Wu PC; Roberson RS; Luk BV; Ivanova I; Chu E; Wu DY
    Int J Cancer; 2011 Apr; 128(7):1546-58. PubMed ID: 20503268
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Escape from therapy-induced accelerated cellular senescence in p53-null lung cancer cells and in human lung cancers.
    Roberson RS; Kussick SJ; Vallieres E; Chen SY; Wu DY
    Cancer Res; 2005 Apr; 65(7):2795-803. PubMed ID: 15805280
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Survivin and p53 modulate quercetin-induced cell growth inhibition and apoptosis in human lung carcinoma cells.
    Kuo PC; Liu HF; Chao JI
    J Biol Chem; 2004 Dec; 279(53):55875-85. PubMed ID: 15456784
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Baicalein induces cancer cell death and proliferation retardation by the inhibition of CDC2 kinase and survivin associated with opposite role of p38 mitogen-activated protein kinase and AKT.
    Chao JI; Su WC; Liu HF
    Mol Cancer Ther; 2007 Nov; 6(11):3039-48. PubMed ID: 18025287
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CIL-102 interacts with microtubule polymerization and causes mitotic arrest following apoptosis in the human prostate cancer PC-3 cell line.
    Huang YT; Huang DM; Guh JH; Chen IL; Tzeng CC; Teng CM
    J Biol Chem; 2005 Jan; 280(4):2771-9. PubMed ID: 15536083
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of CDK1 as a potential therapy for tumors over-expressing MYC.
    Goga A; Yang D; Tward AD; Morgan DO; Bishop JM
    Nat Med; 2007 Jul; 13(7):820-7. PubMed ID: 17589519
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of cyclin-dependent kinase 1-induced cell death in neuroblastoma cells through the microRNA-34a-MYCN-survivin pathway.
    Chen Y; Tsai YH; Tseng SH
    Surgery; 2013 Jan; 153(1):4-16. PubMed ID: 22703967
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interaction between survivin and aurora-B kinase plays an important role in survivin-mediated up-regulation of human telomerase reverse transcriptase expression.
    Furuya M; Tsuji N; Kobayashi D; Watanabe N
    Int J Oncol; 2009 Apr; 34(4):1061-8. PubMed ID: 19287963
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanisms of the anti-tumor activity of Methyl 2-(-5-fluoro-2-hydroxyphenyl)-1 H-benzo[d]imidazole-5-carboxylate against breast cancer in vitro and in vivo.
    Hasanpourghadi M; Pandurangan AK; Karthikeyan C; Trivedi P; Mustafa MR
    Oncotarget; 2017 Apr; 8(17):28840-28853. PubMed ID: 28392503
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phospho-p70S6K and cdc2/cdk1 as therapeutic targets for diffuse large B-cell lymphoma.
    Zhao XF; Gartenhaus RB
    Expert Opin Ther Targets; 2009 Sep; 13(9):1085-93. PubMed ID: 19614561
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Down-regulation of survivin in nitric oxide-induced cell growth inhibition and apoptosis of the human lung carcinoma cells.
    Chao JI; Kuo PC; Hsu TS
    J Biol Chem; 2004 May; 279(19):20267-76. PubMed ID: 14988404
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phospho-p70S6K/p85S6K and cdc2/cdk1 are novel targets for diffuse large B-cell lymphoma combination therapy.
    Zhao MY; Auerbach A; D'Costa AM; Rapoport AP; Burger AM; Sausville EA; Stass SA; Jiang F; Sands AM; Aguilera N; Zhao XF
    Clin Cancer Res; 2009 Mar; 15(5):1708-20. PubMed ID: 19223503
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Induction of survivin expression by taxol (paclitaxel) is an early event, which is independent of taxol-mediated G2/M arrest.
    Ling X; Bernacki RJ; Brattain MG; Li F
    J Biol Chem; 2004 Apr; 279(15):15196-203. PubMed ID: 14722122
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tetra-O-methyl nordihydroguaiaretic acid inhibits growth and induces death of leukemia cells independent of Cdc2 and survivin.
    Mak DH; Schober WD; Chen W; Heller J; Andreeff M; Carter BZ
    Leuk Lymphoma; 2007 Apr; 48(4):774-85. PubMed ID: 17454637
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tetra-O-methyl nordihydroguaiaretic acid induces growth arrest and cellular apoptosis by inhibiting Cdc2 and survivin expression.
    Chang CC; Heller JD; Kuo J; Huang RC
    Proc Natl Acad Sci U S A; 2004 Sep; 101(36):13239-44. PubMed ID: 15329416
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The anti-apoptosis protein, survivin, mediates gastric epithelial cell cytoprotection against ethanol-induced injury via activation of the p34(cdc2) cyclin-dependent kinase.
    Jones MK; Padilla OR; Webb NA; Norng M
    J Cell Physiol; 2008 Jun; 215(3):750-64. PubMed ID: 18181150
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A moderate static magnetic field enhances TRAIL-induced apoptosis by the inhibition of Cdc2 and subsequent downregulation of survivin in human breast carcinoma cells.
    Lin T; Wan L; Qi X; Shi W; Lin J
    Bioelectromagnetics; 2014 Jul; 35(5):337-46. PubMed ID: 24619849
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phosphorylation of survivin at threonine 34 inhibits its mitotic function and enhances its cytoprotective activity.
    Barrett RM; Osborne TP; Wheatley SP
    Cell Cycle; 2009 Jan; 8(2):278-83. PubMed ID: 19158485
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New alternative phosphorylation sites on the cyclin dependent kinase 1/cyclin a complex in p53-deficient human cells treated with etoposide: possible association with etoposide-induced apoptosis.
    Higginbottom K; Jahnke U; Newland AC; Cotter FE; Allen PD
    Apoptosis; 2007 Oct; 12(10):1847-55. PubMed ID: 17636382
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Survivin mediates self-protection through ROS/cdc25c/CDK1 signaling pathway during tumor cell apoptosis induced by high fluence low-power laser irradiation.
    Chu J; Wu S; Xing D
    Cancer Lett; 2010 Nov; 297(2):207-19. PubMed ID: 20579806
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.